ADAPTIVE BIOTECHNOLOGIES COR's ticker is ADPT and the CUSIP is 00650F109. A total of 227 filers reported holding ADAPTIVE BIOTECHNOLOGIES COR in Q3 2022. The put-call ratio across all filers is 0.59 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $86,977 | -89.7% | 15,959 | -87.4% | 0.01% | -90.6% |
Q2 2023 | $847,762 | -10.8% | 126,343 | +17.4% | 0.12% | -9.3% |
Q1 2023 | $950,629 | +15.6% | 107,659 | +0.0% | 0.13% | -3.0% |
Q4 2022 | $822,393 | +116.4% | 107,643 | +101.9% | 0.13% | +129.3% |
Q3 2022 | $380,000 | -21.6% | 53,325 | -11.0% | 0.06% | +34.9% |
Q2 2022 | $485,000 | -42.0% | 59,893 | -0.6% | 0.04% | -40.3% |
Q1 2022 | $836,000 | -64.7% | 60,252 | -28.5% | 0.07% | -60.0% |
Q4 2021 | $2,365,000 | -28.9% | 84,300 | -13.9% | 0.18% | -24.7% |
Q3 2021 | $3,327,000 | -15.0% | 97,872 | +2.2% | 0.24% | -7.7% |
Q2 2021 | $3,915,000 | +2.9% | 95,804 | +1.4% | 0.26% | -5.1% |
Q1 2021 | $3,805,000 | -40.9% | 94,516 | -13.3% | 0.27% | -37.2% |
Q4 2020 | $6,443,000 | -21.1% | 108,959 | -35.1% | 0.44% | -19.3% |
Q3 2020 | $8,170,000 | +1521.0% | 168,007 | +1513.4% | 0.54% | +1485.3% |
Q2 2020 | $504,000 | – | 10,413 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Eagle Health Investments LP | 1,014,860 | $14,086,000 | 3.47% |
Triatomic Management LP | 297,048 | $4,123,000 | 3.35% |
Diametric Capital, LP | 265,000 | $3,678,000 | 2.03% |
Matrix Capital Management Company, LP | 11,572,590 | $160,628,000 | 1.93% |
VIKING GLOBAL INVESTORS LP | 29,993,708 | $416,313,000 | 1.68% |
TIGER MANAGEMENT L.L.C. | 589,311 | $8,180,000 | 1.35% |
Aristotle Atlantic Partners, LLC | 759,412 | $10,541,000 | 0.65% |
Casdin Capital, LLC | 1,000,000 | $13,880,000 | 0.62% |
Pier Capital, LLC | 339,541 | $4,713,000 | 0.60% |
Leeward Financial Partners, LLC | 68,504 | $951,000 | 0.59% |